The patented technology enables creation of biodegradable polymer devices with unique drug delivery capabilities. Initial product development focuses on vascular stents. By using biodegradable polymers with second-generation drugs such as growth factors or enzymes, TissueGen is designing vascular stents that offer breakthrough treatment capability.